The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
COVID‐19: a major cause of cachexia and sarcopenia?
Open accessAbstract
Coronavirus disease (COVID-19) has reached pandemic proportions. Two animal studies have shown that coronavirus-2 causes weight loss in animals associated with an increase in inflammatory cytokines. In humans, COVID-19 causes anorexia, weight loss and low albumin. While poorly studied, this suggests that severe COVID-19 is associated with cachexia. The angiotensin converting enzyme 2 is the receptor for coronavirus-2, and it occurs in skeletal muscle. Persons with COVID-19 have myalgias and muscle loss. This coupled by bed rest and being ventilated can lead to severe sarcopenia during the recovery period following COVID-19. Coronavirus 2 disease (COVID-19) is a pandemic that swept around the world.1 The disease starts as a nasopharyngeal infection; it can sweep through the body infecting almost every organ (Figure 1). The coronavirus-2 spikes protein, uses the angiotensin converter enzyme 2 (ACE2) receptor to bind to a cell resulting in fusion of the viral envelope to fuse with cell membrane and allows the viral genetic material to enter the cell.2 ACE2 receptors are present ubiquitously throughout the body resulting in a variety of tissue damages. It is important to recognize that many persons infected with coronavirus-2 have no or minimal symptoms. Others develop severe disease. People at highest risk appear to be those with comorbidity, diabetes, hypertension, smokers and older individuals.3 Cachexia is defined by our society as 'a complex metabolic syndrome associated with underlying illness and characterized by loss of muscle.'4 Its clinical features are weight loss, low albumin, anorexia, increased muscle protein breakdown and inflammation. Weight loss is a feature of COVID-19 and was clearly demonstrated by the CNN television host who lost 13 pounds over 2 weeks while infected with COVID-19. Both myalgias and muscle loss have been seen in COVID-19.5 Muscle has an ACE2 receptor which might in part explain these effects. Persons with COVID-19 also have hypoalbuminemia and elevated levels of C-reactive protein and a number of inflammatory cytokines such a tumour necrosis alpha, interleukin-1 and interleukin-6.6, 7 A further cause of muscle loss and weakness is the immobilization seen in mechanically ventilated patients in the intensive care unit.8 Anorexia is a component of COVID-19.1 This is, in part, due to the anosmia and loss of taste that occurs in COVID-19, but is also secondary to the elevated levels of inflammatory cytokines, which are common causes of anorexia.9 When Syrian hamsters are injected with coronavirus-2, they develop typical signs of COVID-19 as well as weight loss.10, 11 This is associated with increases in interferonδ and tumour necrosis alpha. Mice infected with coronavirus-2 had had significant weight loss which was reversed by a ribonucleoside analog.12 Sarcopenia is defined as the decreased muscular function in the presence of muscle loss.13 Primary sarcopenia is age related while secondary sarcopenia is when the sarcopenia is related to a chronic disease such as diabetes mellitus or chronic obstructive pulmonary disease.14 In older persons, the need for social isolation during the COVID-19 pandemic has led to a decrease in daily physical activity which accelerates the loss of muscle strength and function. Persons with diagnosed COVID-19 are also likely to have 2 or 3 weeks of decreased function resulting in secondary sarcopenia. Following COVID-19, a number of persons have lung damage with hypoxemia. High-altitude hypoxia leads to loss of fat-free mass and physical disability.15 Persons who are physically isolated should be given recommendations to do daily exercises such as the ViviFrail graded exercise set (16 vivifrail.com). There is evidence that persons in hospital have better outcomes if they receive exercise therapy during hospitalization.17 There is evidence that persons with severe COVID-19 need prolonged exercise therapy to prevent or reverse disability.18 Cachexia and sarcopenia are major causes of mortality and disability. Persons who survive cachexia often require long periods of rehabilitation. Similarly, persons who develop sarcopenia secondary to a stressful event often require lifetime exercise and nutrition therapy. We need more research into the incidence of cachexia in COVID-19 and also more attention to rehabilitation during the recovery phase.19 The authors declare there are no conflicts of interest. The authors certify that they comply with the ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.20
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Arai, H., Kritchevsky, S. B., Guralnik, J., Bauer, J. M., Pahor, M., Clark, B. C., Cesari, M., et al. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1139-9 · Cited by 1,130 · cited 1×
“Primary sarcopenia is age related while secondary sarcopenia is when the sarcopenia is related to a chronic disease such as diabetes mellitus or chronic obstructive pulmonary disease.(14) In older persons, the need for social isolation during the COVID-19 pandemic has led to a decrease in daily physical activity which…”
BackgroundSelf-citationClinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792 · cited 1×
“A further cause of muscle loss and weakness is the immobilization seen in mechanically ventilated patients in the intensive care unit.(8) Anorexia is a component of COVID-19.”
Background
Cited by
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Raman, B., Bluemke, D. A., Lüscher, T. F., & Neubauer, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac031 · Cited by 650
Neuromuscular presentations in patients with COVID-19
Paliwal, V. K., Garg, R. K., Gupta, A., & Tejan, N. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04708-8 · Cited by 266
Metadata
- Authors
- Morley, J. E., Kalantar‐Zadeh, K., & Anker, S. D.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2020-06-09
- Volume
- 11
- Issue
- 4
- Pages
- 863-865
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W3033878123
- Cited by
- 197
- References
- 3
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COVID‐19: a major cause of cachexia and sarcopenia? https://app.cochat.ai/papers/10.1002/jcsm.12589
- The paper
- Morley, J. E., Kalantar‐Zadeh, K., & Anker, S. D. (2020). COVID‐19: a major cause of cachexia and sarcopenia? Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.